•   
  •   
  •   

Politics CDC tells Congress it urgently needs $6 billion for vaccine distribution

14:22  18 september  2020
14:22  18 september  2020 Source:   thehill.com

Russia vaccine data questioned by experts worried about global distribution

  Russia vaccine data questioned by experts worried about global distribution A growing chorus of experts is calling on Russian scientists to explain potential discrepancies in the data supporting the country's COVID-19 vaccine, dubbed Sputnik V. © Alexander Zemlianichenko Jr./AP A Russian medical worker administers a shot of Russia's Sputnik V coronavirus vaccine in Moscow on Sept. 15, 2020. Russian health authorities have launched trials of the vaccine among 40,000 volunteers, a randomized, placebo-controlled study. Russia was the first country to authorize a COVID-19 vaccine, but it did so before completing proper scientific studies to show it is safe and effective.

The Centers for Disease Control and Prevention says it needs $6 billion that it does not currently have in order to distribute a coronavirus vaccine, highlighting a new hurdle in a massive logistical undertaking.

a man wearing a suit and tie: CDC tells Congress it urgently needs $6 billion for vaccine distribution © New York Times/Pool CDC tells Congress it urgently needs $6 billion for vaccine distribution

The agency had previously privately informed Congress of the need for more funds, according to congressional aides, but CDC Director Robert Redfield made the request public for the first time at a Senate hearing on Wednesday, calling it "urgent."

Data, data and more data is what will make a coronavirus vaccine safe, says USA TODAY's vaccine panel

  Data, data and more data is what will make a coronavirus vaccine safe, says USA TODAY's vaccine panel USA TODAY's expert panel sees steady progress toward a safe and effective COVID vaccine, urge public's patience as trials proceed and data comes in.They know the country longs for normalcy, which only widespread use of a vaccine that makes the majority of Americans immune to COVID-19 can bring. But they remind us a viable vaccine can only come when there’s solid, verifiable and freely accessible research results showing it works and helps more than harms.

"Right now we've leveraged about $600 million, but we do not have the resources to support 64 jurisdictions to get this plan operational, so to me it's an urgency," Redfield said.

"The time is now for us to be able to get those resources out to the state, and we currently don't have those resources," he added.

The need for vaccine distribution funding raises the stakes for Congress to come together on a broader coronavirus deal. While both parties support the vaccine funding, there is no clear path for enacting it outside of a larger deal, which has been stalled for months.

"If you have the vaccine and don't have either the plan or the resources to distribute it, that's a huge failure on the part of the Congress to provide the resources that we know are going to be necessary," Sen. Roy Blunt (R-Mo.), the chairman of the Senate panel that funds health care, said in response to Redfield. "I hope it's part of whatever package we put together this very month to be sure you have the capacity to do that."

Fauci says he will take responsibility if a coronavirus vaccine rolled out in the US is faulty

  Fauci says he will take responsibility if a coronavirus vaccine rolled out in the US is faulty In comments to media outlets Thursday Fauci sought to reassure the public amid a dispute between Trump and the CDC over vaccines."Do you assure all of us that if the corners have been cut, if there is something sideways or wrong with the process, that you will tell us and take the heat for that?" MSNBC's Chris Hayes asked Fauci.

He noted that the coronavirus package that the Senate voted on last week, and which was blocked by Democrats for being too small, included the $6 billion for vaccine distribution, as well as an additional $20 billion that the Department of Health and Human Services says it needs for further vaccine manufacturing and development.

Senate Majority Leader Mitch McConnell (R-Ky.) last week also pointed to vaccine funding in pressuring Democrats to support the GOP bill. "They're going to vote against finding and distributing vaccines because they are afraid the breakthrough that our nation is praying for might possibly help President Trump?" McConnell said on the Senate floor.

Democrats say they support additional funding for a vaccine. "Given that the Senate has not begun its appropriations process, we support inclusion of this funding in a supplemental coronavirus appropriations bill," said a House Democratic aide.

Overnight Health Care: CDC reverses controversial testing guidance | Billions more could be needed for vaccine distribution | Study examines danger of in-flight COVID-19 transmission

  Overnight Health Care: CDC reverses controversial testing guidance | Billions more could be needed for vaccine distribution | Study examines danger of in-flight COVID-19 transmission Welcome to Friday's Overnight Health Care. The CDC reversed its controversial guidance on testing of potentially asymptomatic people. President Trump said he expects enough vaccines to be available for every American by April. And experts warn wildfire smoke could make COVID-19 illness worse.Let's start with the CDC:CDC reverses guidance on COVID-19 testing for asymptomatic peopleThe Centers for Disease Control and Prevention (CDC) on Friday revised controversial guidance that previously stated people without COVID-19 symptoms don't necessarily need to be tested.

But the broader negotiations on a coronavirus package to carry the funding are still deadlocked. Democratic leaders say the GOP bill voted on last week was "emaciated" and lacked needed funding for areas like state and local governments, food aid and rental assistance.

Asked about the vaccine funding, Henry Connelly, a spokesman for Speaker Nancy Pelosi (D-Calif.), said there are a range of priorities that Republicans are refusing to adequately fund.

"Millions of kids are food insecure, families are facing eviction, schools can't reopen safely, more money is desperately needed for testing, tracing and vaccines, there's crisis everywhere you look because Republicans are refusing to acknowledge the seriousness of the situation facing America and pass a bill that meets these needs," Connelly said. "There are massive, urgent needs that have to be met as soon as possible, and Republicans need to stop focusing on doing as little as possible so we can reach an agreement on a bill that will address the health and economic crises gripping our nation."

Trump says U.S. will manufacture enough coronavirus vaccine doses for every American by April

  Trump says U.S. will manufacture enough coronavirus vaccine doses for every American by April President Donald Trump said Friday the U.S. will manufacture at least 100 million coronavirus vaccine doses before the end of the year with enough to inoculate every American by April "Hundreds of millions of doses will be available every month and we expect to have enough vaccines for every American by April and again I'll say even at that later stage, the delivery will go as fast as it comes," Trump said at a White House press briefing.Pfizer and Moderna, frontrunners in the race for a Covid-19 vaccine, did not immediately respond to requests for comment.

A Senate GOP aide said that based on lawmaker and staff discussions with HHS, the $6 billion would be used for "all parts of the distribution process - cold-chain supply (including buying freezers); all the logistics of physically moving the vaccine from manufacturing facilities to states down to pharmacies, or mobile units, or a personal physician," as well as "establishing distribution centers."

Two of the leading vaccines, from Moderna and Pfizer, require storage at sub-zero temperatures, making buying sufficient freezers a key concern.

The Trump administration released a distribution plan on Wednesday, which relies heavily on states, who will choose the vaccination sites in their area.

But the plan also requires money.

"This is a very ambitious endeavor to roll out and vaccinate hundreds of millions of people," said Marcus Plescia, chief medical officer for the Association of State and Territorial Health Officials. "States are going to need resources to do that."

Being able to store the vaccines at the right temperature, in particular, "could be challenging," he said.

The proper cold storage "requires the states to invest in such capacity," said Prashant Yadav, a health supply chain expert at the Center for Global Development. Or as an alternative, he said, the federal government would have to make precise shipments of vaccine every day from its storage areas out to the vaccination sites.

"That is a humongous effort," he said. "It's like taking an Amazon Prime delivery model for a vaccine."

Another question is whether there will be enough vials, needles and syringes to administer the vaccine.

Blunt also said at Wednesday's hearing that "HHS has told us that to have 300 million copies of vaccine available, they need another $20 billion that they don't have in any specifically appropriated line."

HHS Assistant Secretary Robert Kadlec replied that he agreed that $20 billion more is needed, though he did not elaborate.

A Senate GOP aide said the money would be used to "continue to develop and manufacture vaccines, diagnostics, and therapeutics."

Plescia, of the state health officials group, said his organization is hoping Congress reaches a deal.

"We're all kind of banking on the fact that they'll come together on this, especially if it's funding purely for vaccine administration and delivery," he said. "They don't really want to be the stumbling block."

'Are people to be left to die?' Vaccine pleas fill UN summit .
If the United Nations was created from the ashes of World War II, what will be born from the global crisis of COVID-19? Many world leaders at this week’s virtual U.N. summit hope it will be a vaccine made available and affordable to all countries, rich and poor. Many world leaders at this week’s virtual U.N. summit hope it will be a vaccine made available and affordable to all countries, rich and poor. But with the U.S., China and Russia opting out of a collaborative effort to develop and distribute a vaccine, and some rich nations striking deals with pharmaceutical companies to secure millions of potential doses, the U.N. pleas are plentiful but likely in vain.

—   Share news in the SOC. Networks
usr: 0
This is interesting!